These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23909699)

  • 1. Inhibition of capsaicin-driven nasal hyper-reactivity by SB-705498, a TRPV1 antagonist.
    Holland C; van Drunen C; Denyer J; Smart K; Segboer C; Terreehorst I; Newlands A; Beerahee M; Fokkens W; Tsitoura DC
    Br J Clin Pharmacol; 2014 May; 77(5):777-88. PubMed ID: 23909699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the TRPV1 antagonist SB-705498 on the nasal parasympathetic reflex response in the ovalbumin sensitized guinea pig.
    Changani K; Hotee S; Campbell S; Pindoria K; Dinnewell L; Saklatvala P; Thompson SA; Coe D; Biggadike K; Vitulli G; Lines M; Busza A; Denyer J
    Br J Pharmacol; 2013 Jun; 169(3):580-9. PubMed ID: 23441756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPV1 inhibition does not prevent cold dry air-elicited symptoms in non-allergic rhinitis.
    Murdoch RD; Bareille P; Denyer J; Newlands A; Bentley J; Smart K; Yarnall K; Patel D
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):267-76. PubMed ID: 24472402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis.
    Bareille P; Murdoch RD; Denyer J; Bentley J; Smart K; Yarnall K; Zieglmayer P; Zieglmayer R; Lemell P; Horak F
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):576-84. PubMed ID: 23735181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mucosal TRPV1 inhibition in allergic rhinitis.
    Alenmyr L; Greiff L; Andersson M; Sterner O; Zygmunt PM; Högestätt ED
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):264-8. PubMed ID: 21951314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
    Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsaicin for non-allergic rhinitis.
    Gevorgyan A; Segboer C; Gorissen R; van Drunen CM; Fokkens W
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010591. PubMed ID: 26171907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial.
    Khalid S; Murdoch R; Newlands A; Smart K; Kelsall A; Holt K; Dockry R; Woodcock A; Smith JA
    J Allergy Clin Immunol; 2014 Jul; 134(1):56-62. PubMed ID: 24666696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans.
    Chizh BA; O'Donnell MB; Napolitano A; Wang J; Brooke AC; Aylott MC; Bullman JN; Gray EJ; Lai RY; Williams PM; Appleby JM
    Pain; 2007 Nov; 132(1-2):132-41. PubMed ID: 17659837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blinded randomized prospective trial of intranasal capsaicin treatment for nonallergic rhinitis.
    Zebda D; Jiang ZY; Gibson MM; Pham C; Ahmadi S; Floren S; Yao WC; Citardi MJ; Luong AU
    Int Forum Allergy Rhinol; 2021 Jan; 11(1):24-30. PubMed ID: 33045140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced chemosensory sensitivity in patients with idiopathic rhinitis and its reversal by nasal capsaicin treatment.
    Van Gerven L; Alpizar YA; Steelant B; Callebaut I; Kortekaas Krohn I; Wouters M; Vermeulen F; Boeckxstaens G; Talavera K; Hellings PW
    J Allergy Clin Immunol; 2017 Aug; 140(2):437-446.e2. PubMed ID: 28389389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis.
    Bernstein JA; Davis BP; Picard JK; Cooper JP; Zheng S; Levin LS
    Ann Allergy Asthma Immunol; 2011 Aug; 107(2):171-8. PubMed ID: 21802026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomized application regimen study.
    Van Rijswijk JB; Boeke EL; Keizer JM; Mulder PG; Blom HM; Fokkens WJ
    Allergy; 2003 Aug; 58(8):754-61. PubMed ID: 12859554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis.
    Singh U; Bernstein JA; Haar L; Luther K; Jones WK
    Am J Rhinol Allergy; 2014; 28(3):215-24. PubMed ID: 24980233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised trial evaluating the effects of the TRPV1 antagonist SB705498 on pruritus induced by histamine, and cowhage challenge in healthy volunteers.
    Gibson RA; Robertson J; Mistry H; McCallum S; Fernando D; Wyres M; Yosipovitch G
    PLoS One; 2014; 9(7):e100610. PubMed ID: 25047038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, Pharmacokinetics, and Pharmacodynamics Study in Healthy Subjects of Oral NEO6860, a Modality Selective Transient Receptor Potential Vanilloid Subtype 1 Antagonist.
    Brown W; Leff RL; Griffin A; Hossack S; Aubray R; Walker P; Chiche DA
    J Pain; 2017 Jun; 18(6):726-738. PubMed ID: 28188907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis.
    Van Gerven L; Alpizar YA; Wouters MM; Hox V; Hauben E; Jorissen M; Boeckxstaens G; Talavera K; Hellings PW
    J Allergy Clin Immunol; 2014 May; 133(5):1332-9, 1339.e1-3. PubMed ID: 24139494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development.
    Rami HK; Thompson M; Stemp G; Fell S; Jerman JC; Stevens AJ; Smart D; Sargent B; Sanderson D; Randall AD; Gunthorpe MJ; Davis JB
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3287-91. PubMed ID: 16580202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal capsaicin in management of nonallergic (vasomotor) rhinitis.
    Singh U; Bernstein JA
    Prog Drug Res; 2014; 68():147-70. PubMed ID: 24941668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough.
    Belvisi MG; Birrell MA; Wortley MA; Maher SA; Satia I; Badri H; Holt K; Round P; McGarvey L; Ford J; Smith JA
    Am J Respir Crit Care Med; 2017 Nov; 196(10):1255-1263. PubMed ID: 28650204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.